How war propelled tissue repair startup to global success The October 7 attacks unintentionally made MediWound the primary burn treatment in Israel. Now, the company plans to tackle diabetic foot ulcers.

https://www.israel21c.org/how-war-propelled-tissue-repair-startup-to-global-success/ When MediWound’s treatment for severe burn wounds received regulatory approval early last year, the biopharmaceutical company didn’t think the drug would be saving lives of Israelis during its most prolonged war just months later.